Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Artemis Therapeutics, Inc. | exhibit_32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Artemis Therapeutics, Inc. | exhibit_31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Artemis Therapeutics, Inc. | exhibit_31-1.htm |
| 10-K/A - 10-K/A - Artemis Therapeutics, Inc. | zk1719938.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Artemis Therapeutics, Inc. (the “Company”) on Form 10-K/A for the year ended December 31, 2016 as filed with the Securities and Exchange Commission (the “Report”), the undersigned, Peter Payne, Chief Executive Officer of the Company, certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: May 10, 2017
|
|
/s/ Peter Payne .
|
|
|
Peter Payne
|
|||
|
Chief Executive Officer (Principal Executive Officer)
|
|||